This new guidance level will further reduce an already minimal risk from lead exposure in candy.

We believe that nanotechnology will have a transformative effect on cancer diagnosis and treatment. In fact, its impact is already visible in the research being conducted through many of the centers we are announcing today. Through the applications of nanotechnology, we will increase the rate of progress towards eliminating the suffering and death due to cancer.

We will continue to do all we can to protect the public health against these dietary supplements that have been found to cause serious illness and injury.

It will be an important step in our understanding of the genetic components of cancer and the genetic susceptibilities of people affected by cancer.

There are initiatives in place to deter counterfeiters and those who sell fraudulent or phony products to prevent or treat avian flu. The use of unproven flu cures and treatments increases the risk of catching and spreading the flu rather than lessening it because people assume they are protected and safe and they aren't. I consider it a public health hazard when people are lured into using bogus treatments based on deceptive or fraudulent medical claims.

One of the biggest barriers research and academic institutions face is the ability to get discoveries made in the lab into clinical testing. The new Exploratory IND guidance emphasizes the flexibility available to researchers when conducting early clinical testing of these cutting-edge treatments. As we enter the era of personalized medicine, these exploratory approaches enable scientists to take full advantage of new technologies to target the development of more individualized therapies.